By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Cognoptix 

20 Main Street

Acton   Massachusetts  01720  U.S.A.
Phone: 978-263-0005 Fax: 978-263-0015


SEARCH JOBS


Industry
Diagnostics






Company News
Cognoptix Elects Its President And CEO, Paul D. Hartung, As Chairman Of The Board, And Welcomes New Director, Dr. Christine De Los Reyes, Alopexx Enterprises 10/8/2014 7:45:22 AM
Cognoptix Raises Over $15 Million To Fund Pivotal Clinical Trial And Final Product Development Of Eye Test Designed To Identify Early-Stage Alzheimer’s Disease 9/30/2014 11:52:15 AM
Cognoptix President And CEO Paul Hartung Tells Neurotech Investors: "Our Vision Is To Change The Course Of Alzheimer’s Disease By Enabling Early Diagnosis At The Point Of Care." 4/25/2014 9:54:45 AM
Cognoptix President And CEO Paul Hartung Tells Analysts: “Our Vision Is To Change The Course Of Alzheimer’s Disease By Enabling Early Diagnosis At The Point Of Care.” 4/2/2014 7:42:27 AM
Cognoptix Eye Test Generates Robust Results in Clinical Study to Identify Alzheimer’s Disease 2/14/2014 9:51:08 AM
Cognoptix President And CEO Paul Hartung Named "Emerging Medical Technologies Innovator Of The Month" By Life Science Intelligence® 12/5/2013 8:03:53 AM
Cognoptix Eye Test Shows Impressive Results In Clinical Study To Identify Alzheimer’s Disease: 85% Sensitivity And 95% Specificity 11/15/2013 9:26:47 AM
Inventages Portfolio Company, Cognoptix, Demonstrates the Ability to Accurately Identify Alzheimer's Disease 10/4/2013 9:00:27 AM
Clinical Investigators Comment on Their Study of Cognoptix Eye Test Designed to Identify Alzheimer's Disease That Showed Strong Results: 85% Sensitivity and 95% Specificity 9/30/2013 11:20:01 AM
Company Profile for Cognoptix 9/27/2013 9:28:53 AM
12
//-->